Chimeric Antigen Receptor T-cell (CAR-T) therapy is one of the most promising forms of immunotherapy. This technique involves genetically modifying a patient's T-cells to express receptors specific to cancer cells. Once reintroduced into the body, these engineered T-cells can efficiently target and eliminate cancer cells. CAR-T therapy has shown remarkable success in treating certain types of leukemia and lymphoma.
